Increased serum, but not tissue, MIF concentrations were detected in stages I–IV in patients with mild and severe endometriosis, with the highest levels observed in stages III and IV, as well as in patients not receiving oral contraceptives. The gene discussed is MIF; the disease is endometriosis.